.png){kind=logo}
HLH STEERING COMMITTEE
The HLH Steering Committee is responsible for charting strategic direction of the HS in their specified areas, including conduct of clinical trials and engagement with the broader group of investigators interested in HLH.
HLH STEERING COMMITTEE MEMBERS
Scott Canna - Chair Despina Moshous - Vice-Chair Scott Baker Shanmuganathan Chandrakasan Michael Jordan |
Kai Lehmberg
University Medical Center Hamburg-Eppendorf - Hamburg, Germany Term of Office: 2021-2025 Rafal Machowicz Elena Sieni Zhao Wang Takahiro Yasumi |
Current Projects The HLH Steering Committee is focused on facilitating and supporting research and clinical care improvement efforts in the field of HLH and other related hyperinflammatory diseases and process areas. We appreciate the need for clinical trials to obtain rigorous data and the challenges of performing clinical trials due to lack of funds to support clinical trial infrastructure and achieve regulatory compliance at an international level. We believe that the Histiocyte Society HLH Steering Committee can serve an important role in synergizing efforts amongst different institutional, regional, and national groups. We are currently focused on three key activities:
Please reach out if you are interested in participating in either of the first 2 activities or if you would like support (non-financial) of any study efforts: CANNA[email protected]. |
Key questions in our field:
|